publication venue for
- Age as a prognostic factor in small cell lung cancer (SCLC): randomized trial of high dose epirubicin ¿cisplatin (HDEP) versus etoposide ¿cisplatin (EP) in SCLC. A retrospective analysis 2001
- CISPLATIN/GEMCITABINE (CG) VS CISPLATIN/GEMCITABINE/VITORELBINE (CGV) VS SEQUENTIAL DOUBLETS OF GEMCITABINE/VINORELBINE FOLLOWED BY IFOSFAMIDE/VINORELBINE (GV/IV) IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): RESULTS OF A SPANISH LUNG CANCER GROUP PHASE III TRIAL (GECP/98-02) 2001
- Fac versus CMF as adjuvant treatment for operable breast cancer: a Geicam study 2001
- Phase II trial of gemcitabine (GEM) and 48-hour continuous infusion (CI) of 5-fluorouracil (5-FU) as first line treatment for patients with locally advanced and metastatic exocrine pancreatic cancer 2001
- Sequential dose-dense paclitaxel followed by topotecan in untreated extended small-cell lung cancer (SCLC): A spanish lung cancer group phase II study 2001